South Korea RUO Immunoassay Market Size, Share, Opportunities, And Trends By Product Type (Immunoassay Kits, Immunoassay Reagents, Microplate Reader, Microplates, Analyzers (Automated Analyzers, Non-Automated Analyzers), Microplate Washers, Others), By Sample Type (Plasma, Blood Serum, Urine, Saliva, Cell or Tissue Culture Medium, Others), By Application (Oncology, Blood Screening and Toxicology, Infectious Disease, Cardiology, Allergy Diagnostic, Rare and Emerging Condition Diagnostic, Others), By End-User (Research and Academic Laboratories, Pharmaceutical and Biotechnology Companies), And By State - Forecasts From 2025 To 2030

South Korea RUO Immunoassay Market Size:

The South Korea RUO immunoassay market is expected to grow at a CAGR of 16.49% from 2025 to 2030.

South Korea is one of the greying societies in Asia, with an escalating proportion of the elderly population, which stood at 15.73% in 2020, 16.57% in 2021, and 17.47% in 2022, depicting a notable demographic shift. This trend underscores an increasing demand for treatments and diagnoses for chronic diseases like diabetes, cancer, and Alzheimer's. According to the Korean Cancer Association, in total, 273,076 new cancer cases and 81,818 cancer deaths were recorded in 2023. The cancer burden in Korea leads to evaluate and develop treatments, where RUO Immunoassays play a vital role. 

Another, prominent disease affecting the older population is dementia. In 2021, the prevalence of dementia in Korea was estimated to be more than 786,000 with numbers expected to continue to rise. For this, Bredis Healthcare received a grant from the South Korean government, in August 2023, under the Deep Tech TIPS program to enhance the early diagnosis of Alzheimer's disease. 

The grant amounts to KRW 1.7 billion. The company has developed a novel platform for digital immunoassay technology, which showed the ability to detect Alzheimer's biomarkers with a sensitivity 10,000 times greater than current diagnostic methods, capable of detecting blood biomarkers at the femtogram level. The medical device market size of South Korea was valued at $9,198 million by the Ministry of Food and Drug Safety. There are several key players like Koma Biotech Co., Ltd. specializing in supplying reagents, consumables, and equipment for life science research in areas including molecular biology, immunology, cell biology, and genetics. They offer customized manufacturing services to meet specific customer needs and contribute to the development of effective treatments.

South Korea RUO Immunoassay Market Scope:

South Korea RUO Immunoassay Market Segmentation

By Product Type

• Immunoassay Kits
  • Enzyme-Linked Immunosorbent Assay (ELISA) Kits
    • Conventional
    • Manual
  • Radioimmunoassay (RIA Kits)
    • Conventional
    • Manual
  • Chemiluminescent Immunoassay (CLIA) Kits
• Immunoassay Reagents
• Microplate Reader
• Microplates
• Analyzers
  • Automated Analyzers
  • Non-Automated Analyzers
• Microplate Washers
• Others

By Sample Type

• Plasma
• Blood Serum
• Urine
• Saliva
• Cell or Tissue Culture Medium
• Others

By Application

• Oncology
• Blood Screening and Toxicology
• Infectious Disease
• Cardiology
• Allergy Diagnostic
• Rare and Emerging Condition Diagnostic
• Others

By End-User

• Research and Academic Laboratories
• Pharmaceutical and Biotechnology Companies

By City

• Seoul
• Busan
• Incheon
• Daegu
• Others